N. Morrell (Cambridge (Cambridgeshire), United Kingdom), E. Austin (Nashville, United States of America)
Multi-omic profiling in pulmonary arterial hypertension
P. Otero-Núñez (London, United Kingdom), C. Rhodes (London, United Kingdom), J. Wharton (London, United Kingdom), E. Swietlik (Cambridge, United Kingdom), S. Kariotis (Sheffield, United Kingdom), L. Harbaum (London, United Kingdom), M. Dunning (Sheffield, United Kingdom), J. Elinoff (Bethesda, United States of America), N. Errington (Sheffield, United Kingdom), R. Thomson (Sheffield, United Kingdom), J. Iremonger (Sheffield, United Kingdom), G. Coghlan (London, United Kingdom), P. Corris (Newcastle, United Kingdom), L. Howard (London, United Kingdom), D. Kiely (Sheffield, United Kingdom), C. Church (Glasgow, United Kingdom), J. Pepke-Zaba (Papworth, United Kingdom), M. Toshner (Cambridge, United Kingdom), S. Wort (London, United Kingdom), A. Desai (Indianapolis, United States of America), M. Humbert (Paris, France), W. Nichols (Cincinnati, United States of America), . Southgate (London, United Kingdom), D. Trégouët (Bordeaux, France), R. Trembath (London, United Kingdom), I. Prokopenko (Surrey, United Kingdom), S. Gräf (Cambridge, United Kingdom), N. Morrell (Cambridge, United Kingdom), D. Wang (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), M. Wilkins (London, United Kingdom)
|     |
New rare variant associations with distinct phenotypes in patients with pulmonary arterial hypertension revealed with Bayesian inference.
E. Swietlik (Cambridge, United Kingdom), K. Lutz (Cincinnati , United States of America), D. Greene (Cambridge, United Kingdom), M. Pauciulo (Cincinnati , United States of America), T. Tilly (Cambridge, United Kingdom), D. Pandya (Cambridge, United Kingdom), N. Zhu (New York, United States of America), M. Cogliano (Sheffield , United Kingdom), C. Welch (New York, United States of America), A. Coleman (New York, United States of America), . Bioresource Rare Diseases Consortium (Cambridge, United Kingdom), Y. Shen (New York, United States of America), A. Swift (Sheffield , United Kingdom), W. Chung (New York, United States of America), W. Nichols (Cincinnati , United States of America), N. Morrell (Cambridge, United Kingdom), S. Graf (Cambridge, United Kingdom)
| |
Screening of pulmonary arterial hypertension in BMPR2 mutation carriers
D. Montani (Le Kremlin-Bicêtre, France), B. Girerd (Le Kremlin-Bicêtre, France), X. Jaïs (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France), P. Laveneziana (Le Kremlin-Bicêtre, France), E. Lau (Camperdown, Australia), A. Bouchachi (Le Kremlin-Bicêtre, France), S. Hascoet (Le Plessis-Robinson, France), S. Gunther (Paris, France), L. Godinas (Le Kremlin-Bicêtre, France), F. Parent (Le Kremlin-Bicêtre, France), C. Guiganbert (Le Kremlin-Bicêtre, France), G. Garcia (Le Kremlin-Bicêtre, France), D. Chemla (Le Kremlin-Bicêtre, France), P. Hervé (Le Kremlin-Bicêtre, France), M. Eyries (Paris, France), F. Soubrier (Paris, France), O. Sitbon (Le Kremlin-Bicêtre, France), G. Simonneau (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France)
| |
Genetic findings in patients with different forms of pulmonary hypertension
C. Eichstaedt (Heidelberg, Germany), Z. Saßmannshausen (Heidelberg, Germany), H. Gall (Gießen, Germany), A. Ghofrani (Gießen, Germany), H. Seyfarth (Leipzig, Germany), M. Lerche (Leipzig, Germany), M. Halank (Dresden, Germany), P. Xanthouli (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), K. Milger-Kneidinger (Munich, Germany), S. Rosenkrankz (Cologne, Germany), R. Ewert (Greifswald, Germany), M. Lankeit (Berlin, Germany), T. Lange (Regensburg, Germany), K. Hinderhofer (Heidelberg, Germany), E. Grünig (Heidelberg, Germany)
| |
Haploid genetic screening identifies a novel regulator of BMPR2
B. Dunmore (Cambridge, United Kingdom), S. Burr (Cambridge, United Kingdom), P. Upton (Cambridge, United Kingdom), J. Nathan (Cambridge, United Kingdom), N. Morrell (Cambridge, United Kingdom)
| |
Protein truncating mutations in ATP13A3 promote pulmonary arterial hypertension
E. Legchenko (Cambridge, United Kingdom), B. Liu (Cambridge, United Kingdom), J. West (Cambridge, United Kingdom), P. Vangheluwe (Leuven, Belgium), P. Upton (Cambridge, United Kingdom), N. Morrell (Cambridge, United Kingdom)
| |
Phenotype and outcome of PAH patients carrying a TBX4 mutation
P. Thoré (Le Kremlin-Bicêtre, France), B. Girerd (Le Kremlin-Bicêtre, France), X. Jaïs (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France), M. Ghigna (Le Plessis Robinson, France), M. Eyries (Paris, France), M. Levy (Paris, France), C. Ovaert (Marseilles, France), A. Servettaz (Reims, France), A. Guillaumot (Nancy, France), C. Dauphin (Clermont, France), C. Chabanne (Rennes, France), E. Boiffard (La, France), V. Cottin (Lyon, France), F. Perros (Le Plessis Robinson, France), G. Simonneau (Le Kremlin-Bicêtre, France), S. Olivier (Le Kremlin-Bicêtre, France), F. Soubrier (Paris, France), D. Bonnet (Paris, France), M. Remy Jardin (Lille, France), A. Chaouat (Nancy, France), M. Humbert (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France)
| |